Table 1.
Baseline Characteristics Among Incident CVD Cases and Matched Controls
| Incident Cases | Controls | P Value | |
|---|---|---|---|
| Number | 209 | 620 | NA |
| Age, y | 60 | 60 | NA |
| Male sex, % | 66.0 | 66.8 | NA |
| Smokers, % | 32.0 | 19.7 | 0.0002 |
| Diabetes mellitus, % | 24.4 | 15.7 | 0.0042 |
| BMI, kg/m2 | 27.8±4.6 | 26.6±3.8 | 0.0030 |
| Hypertension (>140/90 mm Hg), % | 42.6 | 25.7 | <0.0001 |
| Glucose, mmol/L | 6.1±2.5 | 5.6±1.5 | 0.0004 |
| Insulin, μmol/L | 11.4±7.1 | 10.1±59 | 0.0140 |
| Systolic blood pressure, mm Hg | 148±21.8 | 139±21.2 | <0.0001 |
| Diastolic blood pressure, mm Hg | 98±10.6 | 85±10.4 | <0.0001 |
| Cholesterol, mmol/L | 6.1±1.0 | 6.0±1.2 | 0.1366 |
| HDL, mmol/L | 1.3±0.4 | 1.4±0.4 | 0.0006 |
| LDL, mmol/L | 3.9±1.2 | 3.8±1.1 | 0.4490 |
| Triglycerides, mmol/L | 1.6±1.0 | 1.4±0.8 | 0.0003 |
| hsCRP, mg/L | 2.4 (1.3–4.6) | 1.7 (0.9–3.2) | <0.0001 |
| Anti‐MDA IgM units | 141.0 (112.7–164.3) | 147.4 (123.5–169.6) | 0.0177 |
| Anti‐MDA IgM units men | 130.6 (107.7–155.3) | 143.0 (120.1–165.2) | 0.0010 |
| Anti‐MDA IgM units women | 154.0 (133.7–187.6) | 155.1 (134.7–176.7) | 0.5638 |
Data are presented as percentage, mean±SD, or median with interquartile ranges within parentheses. BMI indicates body mass index; CVD, cardiovascular disease; HDL, high‐density lipoprotein; hsCRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein; MDA, malondialdehyde.